California
Oncology
Weekly
"Where California Oncologists Go For Answers!"
A publication of the
Medical Oncology Association of Southern California, Inc.
June 2, 2020
|
|
|
This
Weekly
's Hot Topics
|
- Vote YES on AB2100 California News
- Gov. Newsome's proposed budget cuts. California News
- House of Representatives passes bill providing flexibility of PPP loans. National News
- Tomorrow, webinar on new Federal Rule to increase drug costs Affiliate Association News
|
|
|
- AB 2100 (Wood) unanimously passed the Assembly Health Committee and is now headed to the Appropriations Committee. In the speed with which this bill seems to be moving, you are encouraged contact the members of the committee today, to urge the passage of AB 2100. AB2100 would make the necessary changes to Medi-Cal's administration of the pharmacy benefit to its beneficiaries, in line with Governor Gavin Newsom's objective of moving the pharmacy benefit out of Medi-Cal Managed Care and into fee-for-service (FFS) without causing undue harm or burden to patients. AB 2100 also corrects the "below-acquisition cost" reimbursement issue caused by the newly adopted methodology mandated by the Affordable Care Act in 2016 and prevents the state from further implementing any 'clawbacks' of claims going back to May of 2017. Please
reach out to the members of the Assembly Appropriations Committee
to vote YES on AB 2100.
-
The list of Gov. Newsome's proposed budget cuts is lengthy. Physicians, dentists and other health care providers who treat Medi-Cal patients also stand to lose $1.2 billion in supplemental Medi-Cal payments that flow from Proposition 56, a tobacco tax that voters approved in 2016. In general, he is wanting to scale back or eliminate programs intended to keep low-income seniors and people with disabilities in their own homes. He proposes to make it easier for the state to collect posthumous payback from deceased Medi-Cal enrollees 55 and older for a broad range of medical costs through the controversial "Estate Recovery Program." He suggests reinstituting stricter income requirements for some older people and those with disabilities to qualify for free Medi-Cal. Whether lawmakers will make the sweeping Medi-Cal cuts the governor has proposed is uncertain. For example, the state Senate plan preserves Medi-Cal funding and assumes Congress will pass another stimulus bill. Both houses of the legislature must come to an agreement and present their version of the budget to the governor for consideration by June 15.
-
The California State Senate adopted a budget plan that
rejects Gov. Newsom's cuts to Medi-Cal and other health care services. The state Assembly is poised to follow suit later this week. Read CMA President Peter N. Bretan, M.D.'s statement on the legislative plans here.
- State workplace safety regulators have received about 30% more complaints against California employers at this time of the year compared to the same period last year, according to data obtained by The San Francisco Chronicle through a public records request. The surge in complaints stem from coronavirus complaints, said Frank Polizzi, a spokesman for the California Division of Occupational Safety and Health.
|
|
|
- Recent Announcements Published to "Latest Updates" of Medicare Jurisdiction E Part B.
- Upcoming Education: Please see Noridian's schedule of events webpage for upcoming trainings on Telehealth and COVID-19. JEA, JEB, JAF, and JFB
- Medicare Physician Fee Schedule (MPFS) Webinar - June 17, 2020. This event includes: Medicare Physician Fee Schedule Basics, Locating fee schedules, Indicator list and descriptors, Resources, Questions and Answers
Read the complete update
- Duplicate Claims Webinar - June 25, 2020.
This event includes: Claim Denial Reasons and Solutions, Repeat Modifiers, Noridian Medicare Portal (NMP), Resources
Read the complete update
|
|
|
-
In light of the extraordinary events of the last several days, MOASC wishes to assure members of our steadfast commitment to be available to you and address your needs.
Although there is not a statewide curfew, several counties and cities, in California, have enacted their own curfew. Residents are urged to check with their own cities to determine if there are curfews. How are these additional encumbrances affecting your ability to care for your patients? Please contact the MOASC Office moasc@moasc.org or 909-985-9061 x1, to share with other members your response to this most unusual circumstance. Thank you.
-
MOASC collaborates with Targeted Oncology™ in an effort to provide members additional clinical education. Each Targeted Oncology™ virtual meeting is designed around a specific disease type, presenting case-based data, driven by peer-dialogue and led by expert physicians. Discussions also include diagnostics, current therapy guidelines and potential treatment options. These meetings are intended for actively practicing oncologists treating patients with the presented disease. Post-meeting and on-site, an HRA® survey will be provided to better understand physicians' educational needs in a regional, live event. You will be offered compensation of $300 by HRA® for your contributions to the meeting and your completion of the short survey.
Skin Cancers will be discussed on Wednesday, June 17, 2020 at 7:00pm to 8:30pm-PDT
. Gino K. In, MD, PhD, Keck School of Medicine, USC will present to those practicing oncologists treating skin cancers. Please register
www.targetedonc.com/events
If you have any questions, please do not hesitate to contact MOASC at
moasc@moasc.org
or 909-985-9061 ext. 1.
- SAVE-THE-DATE MOASC
Physician Webinar on
Thursday, June 18, 2020, 5:30pm PDT.
The California Medicare contractor Medical Director, Arthur Lurvey, MD, FACP, FACE, will discuss "Updates on Dealing with Issues related to the COVID-19 Pandemic". Physicians, NPP's and all interested staff are welcome. The webinar affords physicians to enter into live dialogue with the California Medicare medical director. Objectives:
How to get the latest clinical resources from CMA, CMS, CDC, and NIH
;
The latest federal rules regarding physician payments and loans
;
To differentiate and use various forms of telemedicine to treat patients
;
To improve documentation and correct charts
;
New Preauthorization for selected topics starting July 1st
; and T
he new E&M office definitions to start in 2021.
For more information, and to register for this webinar, contact the MOASC office at moasc@moasc.org or call 909-985-9061 x1.
- SAVE-THE-DATE MOASC LunchTime Series Teleconference
on Wednesday, June 24, 2020 at 12:30pm PDT. Topic: COVID-19 Billing and Coding Updates for Your Cancer Center. Presented by Teri Bedard BA, R.T. (R)(T), CPC,Director, Client Services, Revenue Cycle Coding Strategies. Since March, CMS has updated the coding guidelines and waivers multiple times. Staying up to date can seem daunting with changes happening quickly, this teleconference will highlight the areas you need to know for your cancer center. We will review the changes to telehealth services, supervision, provider-based designations, and coding for services. Objectives: As a result of attending this session, participants will be able to: 1. Understand the changes to telehealth services specific to oncology services; 2. Understand changes to physician supervision for therapeutic services; and 3. Understand how to code for services with necessary modifiers and place of service codes. For more information, and to register for this webinar, contact the MOASC office at moasc@moasc.org or call 909-985-9061 x1.
-
Dear MOASC Members,
As you are aware, our membership year is coming to an end and ramping up for the 2020-2021 year. During these unprecedented times, MOASC continually monitors the public health crisis, the re-opening and economic recovery of the state. The health and well-being of MOASC members, and the patients they serve, are of utmost importance.
In order to support you, your staff and your patients during this difficult time, when cash flow has been negatively impacted, MOASC is extending your membership to October 1, 2020. This will provide you with three months of free membership. The remaining nine months will be assessed at a prorated amount.
MOASC is able to do this with the generous support from our Industry Sponsors: AstraZeneca, Pfizer, Puma Biotechnology, AbbVie, Merck, Verastem, Amgen, Astellas, Bristol Myers Squibb, Johnson & Johnson, Foundation Medicine, Genentech, Genomic Health, Kite Pharma, Eli Lilly, Novartis, Oncology Supply, Regeneron, Sanofi-Genzyme, Stemline Therapeutics and Takeda.
MOASC knows every aspect of your practice has been disrupted and is here to help you adapt to the changes with the necessary tools and resources to be successful.
Together we will continue to advance oncology in California. If you have any questions, please contact the MOASC Office by phone 909-985-9061 ext.1 or at
moasc@moasc.org
.
|
|
|
-
The Association of Northern California Oncologists (ANCO) continues to monitor the novel coronavirus (COVID-19) pandemic and is committed to providing the membership the best possible information with which to make clinical and personal well-being decisions.
We encourage member practices to let ANCO know of COVID-19 resources they are depending upon and found useful and how they are responding to COVID-19 and serving their patients and staff at director@anco.org (Use Subject: COVID-19: RESPONSE). Thanks!
-
Applications period has been extended for ANCO's Travel Awards to Fellows and Young Clinicians to support attendance at the ASCO Annual Meeting, ASH Annual Meeting, or other national oncology meeting in 2020 or 2021. Awards will be announced 30 days after the deadline; funds will be disbursed during the year in which the national meeting to be attended takes place. Learn more at https://anco.org/membership/fellow-benefits/.
-
ANCO physician members, their practice staff, and representatives from ANCO's corporate members must register to access password-protected content (e.g., The ANCO Directory, ANCO meeting materials) on the ANCO website www.anco.org.
- Use ANCO's job board to post or search for employment opportunities at ANCO member practices.
-
Follow ANCO on Twitter at @ANCO News.
|
National News
-
The Trump administration is renewing a push to end unexpected bills for out-of-network care, possibly as part of the next pandemic relief package. Under a proposal being explored, health care providers would be prohibited from billing patients for thousands of dollars in out-of-network care, and billing disputes would be resolved on a case-by-case basis.
-
The House of Representatives
passed a bill this week that will provide flexibility for Paycheck Protection Program (PPP) loans.
-
Legislation meant to thwart "frivolous litigation" targeting health care providers who made "good faith" efforts to provide care during the COVID-19 pandemic has been introduced by Reps. Lou Correa, D-Calif., and Phil Roe, R-Tenn. Care that involves gross negligence or willful misconduct would still be subject to litigation.
-
Get Ready for the Evaluation and Management Changes in 2021
.
On January 1, 2021 significant changes will be coming to the office and outpatient Evaluation and Management services. Begin the process of preparing your practice with these three steps:
For questions regarding the changes (or any other billing and coding questions) contact ASCO staff at billingandcoding@asco.org.
-
A digital pre-visit checklist provided to patients before telehealth appointments improved efficiency of virtual visits
. Though the Journal of Bone and Joint Surgery wrote the paper for orthopedic care at Massachusetts General Hospital, its application can be utilized to success across all specialties utilizing virtual health care. The checklist directs patients to a website to test their camera and microphone settings; guides patients through camera setup, location and lighting; advises them on the best clothing to wear to facilitate a virtual exam; and provides pictures of complex maneuvers.
-
Compliance with evidence-based clinical pathways rose from about 58% over a six-month period to 72% at nine community-based oncology practices in Texas that integrated a physician-designed clinical decision support tool into their EHR systems
, according to a study presented at the American Society of Clinical Oncology's annual meeting. The CDS tool nudges physicians instead of forcing action, and it effectively improved compliance targets broadly and at the individual clinician level, researchers found.
-
A study published in JAMA Network Open showed EHRs consistently fail to detect up to one-third of dangerous drug interactions and medication administration errors in hospitalized patients.
Researchers used an EHR safety evaluation tool to feed simulated medical records into EHRs at 2,314 US hospitals, and the EHRs correctly flagged potential drug problems 66% of the time in 2018, up from 54% in 2009.
-
COA has released the 2020 Community Oncology Practice Impact Report
, which tracks the changes and shifts of community oncology care in the United States. This year's report shows that the last 12 years have been host to closures, financial struggles or mergers, with a 20.8 percent increase in mergers since the last Practice Impact Report in 2018. Other data points include:
435 clinics closed; 348 practices struggling financially; 40 practices sending patients elsewhere; 722 practices acquired by hospitals; 203 practices merged or acquired.
- If you missed The Financial Impact of COVID-19: Bankruptcy 101
presented by: Svetlana (Lana) Ros, Esq. - Member, Healthcare Practice Group at Norris McLaughlin, P.A. and Bruce J. Wisotsky, Esq. - Member, Bankruptcy & Creditors' Rights Practice Group at Norris McLaughlin, P.A. below are the following:
-
Providers Must Act on Application for Provider Relief Fund by June 3
;
HHS' Extends Attestation Deadline.
Background
: $50 billion from the Provider Relief Fund has been allocated by Health and Human Services (HHS) for general distribution to Medicare facilities and providers impacted by COVID-19. To be eligible for the general distribution, a provider must have billed Medicare in 2019. To expedite providers getting money as quickly as possible, $30 billion was distributed immediately, proportionate to providers' share of Medicare fee-for-service reimbursements in 2019. HHS subsequently announced that the agency would begin distribution of the remaining $20 billion of the Fund to providers to augment their allocation so that the whole $50 billion general distribution is allocated proportional to providers' share of 2018 net patient revenue. A portion of providers were automatically sent payment based on the revenue data they submitted in CMS cost reports. Providers without adequate cost report data on file need to submit their revenue information through an application portal on the HHS website. (HHS will likely have cost reports from facilities, but physicians and other providers may need to submit information through the portal.)
IMPORTANT NOTE
- HHS has twice extended the deadline for attestation of acceptance or rejection of provider relief funds, but these extensions do not affect theapplicationdeadline for the second tranche of the general distribution.
Providers will have until June 3, 2020 to access the application portal to submit their revenue/loss information, at which time the application portal will close.
In order to enter the application portal, providers must accept or reject the first distribution of funds. By June 3, 2020, if a provider has not yet decided whether to accept the funds they have already received, they may reject the first set of funds and submit their revenue/loss information to the application portal for consideration. The provider will be reallocated all General Distribution funds they are owed based on their submitted application and will then have 90 days to attest or reject.
|
CMS News
-
Medicare beneficiaries using telehealth rose from around 11,000 the week of March 7 to 1.3 million the week of April 18,
according to claims data. Another survey
of 1,000 Medicare Advantage members
revealed that 24% of Medicare Advantage subscribers said they had used telehealth since the coronavirus pandemic began.
52% said they would be comfortable using telehealth. The survey, commissioned by the Better Medicare Alliance, found 91% of those who used telehealth during the pandemic had a favorable experience and that 99% overall were satisfied with their Medicare coverage.
Avalere's Tim Epple said the uptick represents "five to 10 years of progress taking place in a month and a half," and CMS Administrator Seema Verma says the agency might extend telehealth coverage waivers.
-
CMS hosts varied recurring stakeholder engagement sessions to share information related to the agency's response to COVID-19.
These sessions are open to members of the healthcare community and are intended to provide updates, share best practices among peers, and offer attendees an opportunity to ask questions of CMS and other subject matter experts.
|
Affiliate Association News
|
- Join the Chronic Care Policy Alliance tomorrow, Wednesday, June 3 at 10:30 AM PDT, for a webinar on the State of Chronic Care: How a New Federal Rule will Increase Prescription Drug Costs for Patients. A Policy Discussion for Advocates. Discussion will be on how a federal policy change will leave many patients facing higher out-of-pocket costs for their prescription medications. The recently released 2021 Notice of Benefit and Payment Parameters (NBPP) allows private health insurers to exclude certain co-pay assistance programs, such as cards and coupons, from counting toward deductibles and out-of-pocket maximums. As a result, patients will no longer be able to rely on these critical programs and face increased costs. Federal health policy and advocacy expert Carl Schmid, will provide an overview of the NBPP rule change and key insights into the impact it will have on patients with chronic disease. Learn more about: The vital importance of co-pay assistance to keep medications affordable; Co-pay accumulators and how they work; Why this change to the NBPP is harmful for patients; What CCPA is doing to advocate for patient rights and patient access; How your organization can help keep prescription medicine affordable. REGISTER HERE!
- National Cancer Survivors Day® is Sunday, June 7, 2020. Get a jumpstart on planning your NCSD 2020 event by registering it (free of charge) with the National Cancer Survivors Day Foundation at
ncsd.org/register.
Visit their website at
www.ncsd.org
. To assist you, NCSD national supporter Coping with Cancer® magazine has put together a list of resources specifically for cancer survivors and caregivers. Follow this link to learn about
Coronavirus and Cancer: A list of resources for cancer survivors.
- Register for the June 9 web conference on, "How telehealth can increase access to care and improve healthcare quality." From 11am-12:30pm Pacific, the Agency for Healthcare Research and Quality (AHRQ) presenters will discuss the impact of telemedicine on chronic disease management and the factors that help or hinder the use of telemedicine in urban areas. The Web conference also will cover the evidence about how telehealth can be used routinely and during public health emergencies such as a pandemic.
Learn more and register
.
-
The success of the 2020 Virtual Community Oncology Conference has inspired COA to meet with advocates virtually
, as well. To help cancer patients and advocates get the best possible cancer care in this brave new COVID-19 world, we are hosting our first-ever Virtual Community Oncology Advocacy Summit. The Summit will take place July 15, 2020. More details are coming soon, so sign up to receive the latest updates!
- The International Lung Cancer Congress will hold their 21st Annual meeting on July 23-25, 2020 at the Hyatt in Huntington Beach, and is exclusively extending FREE registrations to MOASC members. This meeting will provide current, practical information on the management of lung cancer, as well as a look at the novel agents and strategies with the potential to shape the future of lung cancer therapy. To register and to view the invitation click HERE.
- The American Society of Hematology (ASH) has decided to transition the ASH Meeting on Hematologic Malignancies to a virtual experience to provide important education while assuring the wellbeing of the hematology community around the world. Registration will open in the next few weeks. Visit their website for schedule updates.
-
Cedars-Sinai 3rd Annual Gastrointestinal Tumor Conference is on Saturday, September 12, 2020. Concise and comprehensive updates on the most recent research and advances in immunotherapy for gastrointestinal cancers, will be presented. A stellar faculty has been assembled to share developments in precision medicine, research, and immunotherapeutic approaches to the treatment of cancers of the pancreas, liver, and gastric/esophagus. For more information and to register go to:
cedars.cloud-cme.com/gicancercme
.
-
If you registered for the 2020 Community Oncology Conference but couldn't make it, every session, along with the virtual exhibit hall, is now available to watch on-demand for FREE.
To access the recordings, visit https://coaconference.com/ and enter the email you used to register.
-
The American Society of Clinical Oncology (ASCO) Nominating Committee is seeking recommendations for potential candidates
for the upcoming ASCO election, for service beginning in June 2021. All members are invited to recommend individuals you believe possess the qualities needed to lead the Society in the future. Your participation in this process will help ensure that our Society's leaders represent the diversity of our membership. Please contact
|
Industry News
- Bristol-Myers Squibb Co. announces the FDA approval of the combination of nivolumab (OPDIVO) plus ipilimumab (YERVOY) and 2 cycles of platinum-doublet chemotherapy as first-line treatment for patients with metastatic or recurrent non-small cell lung cancer (NSCLC), with no epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) genomic tumor aberrations. More Information
- Genentech
announced that the Food and Drug Administration approved atezolizumab in combination with bevacizumab (TECENTRIQ and AVASTIN) for patients with unresectable or metastatic hepatocellular carcinoma who have not received prior systemic therapy. The Genentech press release including Important Safety Information is linked here, and a press release issued by the FDA about the approval is linked here.
- Eli Lilly and Company
announced that the Food and Drug Administration approved ramucirumab (CYRAMZA) in combination with erlotinib for first-line treatment of metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) mutations. For more information click here
-
RxVantage held an expert roundtable, "Oncology Operational Excellence During COVID-19," discussing how panelists and their practices are navigating the current moment and their plans for the way forward. The panel was composed of leaders from across the oncology specialty, here is the video link.
RxVantage has also provided
the link
to their new on-demand webinar on safely reopening amid COVID-19. This webinar covers policy recommendations for dealing with your rep/vendor community and recommendations for updating protocols to fit social distancing guidelines. If you have any questions please contact Alexis Johnson at
alexis.johnson@rxvantage.com
, or 989.529.6020.
|
|
|
MOASC CALENDAR
"Updates on Dealing with Issues related to the COVID-19 Pandemic"
June 18, 2020
COVID-19 Billing and Coding Updates for Your Cancer Center.
June 24, 2020
(Davis, New Dates:
March 11-12, 2021)
|
|
|
|
|
The
Medical Oncology Association of Southern California
(MOASC) is a leading oncology society that advances and protects the ability of cancer patients to obtain, and the ability of the oncology physicians to provide, optimal cancer care.
The material contained in the
California Oncology Weekly
is intended as general information for MOASC members. Because diagnostic, treatment, contracting, coding, and billing decisions should be made on a case-by-case basis, any such information contained in the
California Oncology Weekly
may not apply in any given situation. Members are encouraged to contact their own consultants or advisors to obtain specific advice on matters relating to contracting, coding, and billing. The information contained in
California Oncology Weekly
should not be used as a substitute for such advice.
This publication provides a summary of regulations affecting oncology and its business practices. Reading this newsletter does not substitute for understanding regulations and verifying the validity of every claim. This information is time-sensitive and is subject to change. MOASC accepts no liability for any statements or articles herein.
CPT codes are owned and trademarked by the American Medical Association. All Rights Reserved.
MOASC: P.O. Box 161, Upland, CA 91785 | P (909) 985-9061 | F (909) 804-5006| www.moasc.org
|
|
| |
|
